Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2020-02-14
06:11 am
Purchase
13GEnlivex Therapeutics Ltd.
ENLV
Nussbaum Ran68,580
0.7%
68,580increase
(New Position)
View
2019-09-09
4:08 pm
Sale
13GEnlivex Therapeutics Ltd.
ENLV
Hobi Michael498,432
4.93%
-192,878decrease
(-27.90%)
View
2019-06-27
3:10 pm
Purchase
13GEnlivex Therapeutics Ltd.
ENLV
HBL- HADASIT BIO-HOLDINGS LTD.1,798,727
17.79%
1,798,727increase
(New Position)
View
2019-06-26
12:16 pm
Purchase
13GEnlivex Therapeutics Ltd.
ENLV
Kretzmer & Associates PLLC830,973
8.22%
830,973increase
(New Position)
View
2019-06-26
10:52 am
Purchase
13GEnlivex Therapeutics Ltd.
ENLV
KIP Global Pharma-Ecosystem Private Equity Fund1,417,950
14.02%
1,417,950increase
(New Position)
View
2019-06-19
3:07 pm
Purchase
13GEnlivex Therapeutics Ltd.
ENLV
Hobi Michael691,310
6.84%
691,310increase
(New Position)
View
2019-05-31
12:17 pm
Purchase
13DEnlivex Therapeutics Ltd.
ENLV
NOVIK SHAI A882,515
8.6%
882,515increase
(New Position)
View
2019-02-14
10:20 am
Sale
13GEnlivex Therapeutics Ltd.
ENLV
Nussbaum Ran505,802
15.1%
-2,250decrease
(-0.44%)
View
2019-02-14
06:10 am
Sale
13GEnlivex Therapeutics Ltd.
ENLV
Gilboa Udi0
0%
-468,700decrease
(Position Closed)
View